Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
If the drugs really do everything, why arent we all on it
In the phase 3 ATTAIN-2 trial , adults with obesity and type 2 diabetes who took orforglipron lost an average of 5.1%9.6% over 72 weeks, compared to 2.5% in those who took a placebo
Research-use-only context
This innovative treatment could change your life if you worry about heart health, blood sugar levels, or other weight-related issues
Ward A, Tardiff S, Dye C, Arrighi HM
US$ 22.71
US$ 26.61
US$ 25.65
US$ 26.34
